🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

If looking for rapid accrual to a prostate cancer-related clinical trial, go no further than Society of Urologic Oncology Clinical Trials consortium (suoctc.org) 94 active sites, experienced investigators, diverse patients/settings Contact me or [email protected]

Potential game-changer, impressive long-term work by scientists and trialists. Will likely be approved soon and become common. Reminder: ain't perfect, don't assume 100% accuracy, know the sens/spec/PPV/NPV thelancet.com/journals/lanon…

Nonsensical Interstate Telehealth Laws are Perplexing and Frustrating. None other than Sean McBride is a plaintiff in an important lawsuit to potentially improve the landscape State Medical Boards and Interstate Telemedicine in the Courtroom jamanetwork.com/journals/jama/…

A lot to unpack but intriguing; more work to be done West African Genetic Ancestry, Neighborhood Deprivation, and Prostate Cancer jamanetwork.com/journals/jaman…

You have to hear this "brilliant" idea from 𝙳𝚊𝚟𝚒𝚍 𝙲𝚊𝚗𝚎𝚜 who formed WellPrept to "personalize" educating patients while reducing #burnout for physicians. Sounds too good to be true? hear this entrepreneur on this #HealthcareUnfiltered episode. Scott Eggener will listen. Full video.

Summary of “CAncer or Not Cancer?: Evaluating and Reconsidering GG1 prostate cancer (CANCER-GG1?)” symposium with ~50 folks from AnCan Foundation , Active Surveillance Patients International, Prostate Cancer Foundation, Movember USA, CDC/NCI, thyroid/breast cancer experts, and all sorts of PrCa disciplines. academic.oup.com/jnci/article/d…

Is there reliable randomized data in any solid organ cancer that a more extended LND improves survival?? nejm.org/doi/full/10.10…

Whether you are an advocate of thoughtful PSA screening and treatment of localized disease OR argue vociferously against it, please digest this 30 year data (and remember it was largely palpable disease) nejm.org/doi/full/10.10…

Data suggesting more people with PrCa (current or treated) should be getting timely organ transplants. Zero evidence (to my knowledge) immunosuppression alters natural history of PrCa. Tanya Watts Kristof Aaron Dahmen Todd 〽️ Morgan, MD bjui-journals.onlinelibrary.wiley.com/doi/10.1111/bj…

Powerful essay by co fellow and close friend Joe Pettus. Some new twist and insights into the age-old “when the doctor becomes patient” When One Day Becomes Today jamanetwork.com/journals/jama/…

More data/modeling to inform the GG1/Gleason 6 relabeling debate. Projected Outcomes of Reduced-Biopsy Management of Grade Group 1 Prostate Cancer: Implications for Relabeling academic.oup.com/jnci/article-a…

G-Minor-ambitious, exciting, and a clinically relevant question: Kudos to MUSIC patients/investigators: sciencedirect.com/science/articl… Editorial by Stan Liauw and me: sciencedirect.com/science/articl… Plz discuss Todd 〽️ Morgan, MD Daniel E Spratt Khurshid Ghani Kevin Ginsburg Rod Dunn Brent Hollenbeck

Déjà vu......both the excellent early results and the predictable blowback jamanetwork.com/journals/jama/…

World champ?? Ronald Weiss was known to perform 14 vasectomies in a day and was done by lunch wsj.com/health/ronald-… via The Wall Street Journal

Powerful data, we can/should do better Similar/better benefit than many extraordinarily expensive drugs Right up alley of Rich Matulewicz, Andrea King UofC jamanetwork.com/journals/jamao…

We asked three big-brained superstars to share thoughts on a very important topic...... My $0.02: "potentially clinically significant" far more accurate than "clinically significant" auajournals.org/doi/10.1097/JU…

Experts Are Debating Whether Some Cancers Shouldn’t Be Called That jamanetwork.com/journals/jama/…

'Cancer' labeling: article largely about DCIS, but endless analogies to Gleason 6/Grade Group 1 prostate cancer Hopefully, tides are a turning..... nytimes.com/2025/01/28/hea…

Wide variety of opinions, specialties, patient perspectives, policy makers contributing discussion to a public health conundrum: save lives from PrCa while minimizing overDxRx academic.oup.com/jnci/article-a…

Yet another thought-provoking piece by Dr Welch Would be great to see contemporary RCT's in this space (challenges galore) Routine Surveillance for Cancer Metastases — Does It Help or Harm Patients? | New England Journal of Medicine nejm.org/doi/full/10.10…